NON-ANTIBACTERIAL ALTERNATIVE MEASURES FOR THE TREATMENT OF URINARY TRACT INFECTION IN CHILDREN. PART 2**. SUPPRESSION OF THE CONSEQUENCES OF MICROBIAL INITIATION OF INFLAMMATION
https://doi.org/10.21508/1027-4065-2018-63-4-113-118
Abstract
The data on the effectiveness of the use of medicinal products, aimed at increasing the antibacterial resistance of the urinary tract («therapeutic vaccines», immunotropic medications), as well asthe minimization of pathological processes(inflammation, oxidative stress) as a result of exposure to infectious microorganisms are presented. Brief information is given on the possibility of slowing nephrosclerotic processes using angiotensin converting enzyme inhibitors, as well as on the prospects of renoprotection on experimental models.
About the Authors
V. I. Kirillov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Moscow
Russian Federation
Moscow
N. A. Bogdanova
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Moscow
Russian Federation
Moscow
S. L. Morozov
Research and Clinical Institute for Pediatrics named after Academician Yu.E. Veltischev of the Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Kovalchuk L.V., Gonkovskaya L.V., Meshkova R.Ya. Clinical Immunology and Allergology with the Basics of General Immunology. Moscow: GEOTAR–Media 2011; 640. (in Russ)
2. Neveus T. Can postpyelonephritic renal scarriny be prevented? Pediatr Nephrol 2013; 28(2): 187–190. DOI: 10.1007/S00467-012-2334-2
3. Urinary tract infection in children. A guide for doctors. V.V. Dlin, I.M. Osmanov, O.L. Chugunova (eds). Moscow: «Overlej» 2017; 422.
4. Antimicrobial therapy and prophylaxis of infections of the kidneys, urinary tract and male genital organs. Russian national recommendations. O.I. Apolikhin, D.Yu. Pushkar, A.A. Kamalov (eds). Moscow 2015; 64. (in Russ)
5. Naumova V.N., Dumnova A.G., Vistenetskaya L.I., Larуonysheva R.D., Golokonova A.S. Efficiency of specific immunotherapy of chronic pyelonephritis in childhood. Symposium «Сhronic pyelonephritis in children». Theses of reports. Moscow 1980; 149–150. (in Russ)
6. Nayir A., Emre S., Sirin A., Alpay H., Tanman F. Encrease of IgA secretory component concentration in the urine after vaceination with inactivated uropathogenic bacteria. Pediatria 1993; 7(2): 41.
7. Zorkin S.N., Pinemis V.G., Areneva E.N., Shakhnovsky D.S. Experience in the use of drugs uro-vaccine for complicated infections of the urinary tract in children. Effectivnaja pharmacotherapyja. Pediatrija 2014; 16(2): 40–42. (in Russ)
8. Guidelines on urological infections (EAV 2013) www.uroweb.org/gls/pdf/118_urological1%20infections_LR.pdf
9. Perepanova T.S., Volkova E.N., Akhmatova N.K., Homenkov V.G., Ahmatova A.A. Effect of the drug uro-vaccine on the cytokine status of patients with recurrent urinary tract infection. Rational pharmacotherapy in urology. Theses of the 10th All-Russian Conference. Moscow: Medforum 2016; 74–76 (in Russ)
10. Glauser M.P., Francioli P.B., Bille J., Meylan P., Roberts J.A., Kaack B. et al. Effect of Indomethacin on the incidence of experimental Escerichia coli pyelonephritis. Infect Immunol 1983; 40(3): 529–533.
11. Ezersky R.F., Sklyarov S.D. Complex pathogenetic therapy of non-obstructive pyelonephritis in children. Chronic pyelonephritis. Moscow 1980; 139. (in Russ)
12. Hilkens C., Vermenlen H., van Neerven R. Snijdewint F.G, Wierenga E.A., Kapsenberg M.L. The differential modulation of Th1 and Th2 cytokine secretion by PGE2 сritically depends on interleukin -2. Eur J Immunol 1995; 25(1): 59–63.
13. Polunin L.I., Tebloeva L.G., Kirillov V.I., Dmitrieva N.G. Activity of suppressor cells in pyelonephritis in children. Pediatriya 1986; 2: 16–19. (in Russ)
14. Bleindorn J., Gagyor L., Kochen M.M., Wegscheider K., Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (cipro-floxacin) for uncomplicated urinary tract infection & Results of a randomized controlled pilot trial. BMC medicine 2010; 8: 30–37.
15. Norbek G., Alidjanov Zh.R. Are there alternative methods for antibiotic therapy and prevention of uncomplicated urinary tract infections? Urology 2014; 6: 25–33 (in Russ)
16. Ragnarsdottir B., Svanborg C. Suscaptibility to acute pyelonephritis orasymptomaticbacteriuria: host-pathogen interaction in urinary tract infecteons. Pediatr Nephrolog 2012; 27(11): 2017–2029. DOI: 10/007/s00467-011-2089-1
17. Soborio P., Krieg R.J., Kuemmerle N.B. Norkus E.P., Schwartz C.C., Chan J.C.M. α-Tocopherol modulates lipoprotein cytotoxicityin obstructive nephropathy. Pediatr Nephrol 2000; 14 (8/9): 740–746.
18. Letifov G.M., Khorunzhy G.V., Belovolova R.A., Polyanskaya F.L., Perfilyev Yu.L. Characterrize of chiersyndromes on pyelonephrition children. Medicinskiy vestnik Uga Rossia 2012 (Prilozhenye); 49. (in Russ)
19. Emamghorashi T., Owji S.М., Motamedifar M. Evaluation of effectiveness of vitamins C and E on prevention of renal scar due to pyelonephritis in rat. Adv Urol 2011; 2011: 489496. DOI: 10.1155/2011/489496
20. Lee H.S., Jeong J.Y., Kim B.C., Kim Y.S., Zhang Y.Z., Chung H.K. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focial segmental glomerulosclerosis. Kidney Int 1997; 51: 1151–1159.
21. Prizzheva E.Yu., Lebed'ko O.A. Characteristic of oxidative status in children with chronical pyelonephritrs in stage of relapse and remission at background innate defect of urinary tract system. Dalnevostochniy medicinskiy zhurnal 2009; 2:67–69 (in Russ)
22. Sobouti B., Hooman N., Movahed M. The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephitis. Pediatr Nephrol 2012; 28(2): 277– 283. DOI: 10/1007/s00467-012-2308-4
23. Khimova Yu.A. Monitoring of bioradical processes in children with pyelonephritis and the possibility of their correction. Thesis author Ph.D. Smolensk 2013; 23 (in Russ)
24. Manucha W., Valles P.G. Apoptosis modulated by oxidative stress and inflammation during obstructive nephropathy. Inflamm allergy drug. Targets 2012; 11(4): 303–312.
25. Jun M., Venkataraman V., Razavian M., Cooper B., Zoungas S., Ninomiya T. et al. Antioxidants for chronic kidney disease. Cochrane dafabase sys rev. 2012; 10: CD008176. DOI:10.1002/14651885. CD 008176
26. Yoshiara S., White R.H.R., Raafat F. Glomerular morphometry in reflex nephropathy: functional and radiological correlations. Pediatr Nephrol 1993; 7(1): 15–22.
27. Mathekhina L.Yu., Nikolaev S.N., Menovshchikova L.B., Gurevich A.G. The use of the ACE inhibitor enap for the purpose of nephroprotection in children with nephropathy. Nephropathy and dialysis 2007; 9 (3): 357–358. (in Russ)
28. Gomez R.A., Pipilli C., Everett A.D. Molecular and cellular aspects of renin during kidney ontogeny. Pediatr Nephrol 1991; 5: 80–87.
29. Pergola P.E., Raskin P., Toto R.D., Meyer C.J., Huff J.W., Grossman E.B. et al. BEAM Study Investigators: Bardoxolone methyl and kidney function in type 2 diabets. N Engl J Med 2011; 365: 327–336.
30. Shvetsov M.V., Bobkova I.N., Kolina I.B., Kamyshova E.S. Chronic kidney disease and nephroprotective therapy. Part 3. Profilactic RCD, mechanisms of progression and ways of its stopping, nephroprotective strategy. Nefrologiya 2012; 22 (6): 69–75. (in Russ)
Review
For citations:
Kirillov V.I., Bogdanova N.A., Morozov S.L. NON-ANTIBACTERIAL ALTERNATIVE MEASURES FOR THE TREATMENT OF URINARY TRACT INFECTION IN CHILDREN. PART 2**. SUPPRESSION OF THE CONSEQUENCES OF MICROBIAL INITIATION OF INFLAMMATION. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2018;63(4):113-118. (In Russ.) https://doi.org/10.21508/1027-4065-2018-63-4-113-118
Views:
839
Email this article 